About usSign in
Status
ACTIVE
Global HQ
Tokyo, Japan
Countries of investment
  • USA: New York
  • California
  • New Mexico
  • Massachusetts
  • Virginia
Investment stages
  • Seed
Industries
  • Pharmaceuticals
  • Diagnostics
  • Bio Tech
  • Therapeutics
  • Health Tech
  • -
About
Axil Capital is a venture capital firm based in Tokyo, specializing in biomedical and healthcare technology investments. They focus on supporting the growth of earlystage ventures by providing capital, expertise, and strategic partnerships.
Min check size
$500K
Max check size
$10M
Fund size
NPS

Investment Thesis

They Invest in innovative biomedical and healthcare technology startups, leveraging their global network and resources to support earlystage ventures.
Lead investor
Co Invest
Number of exits
Preferred contact method

Team

Yoshikazu Hayakawa Managing Partner

Shunsuke Sugimoto Partner

Takeshi Sakurai Principal

Portfolio

Hirosaki LI

GEXVal

Eurus Therapeutics

Cellusion

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp